Long-Term Cardiac Safety Analysis of NCCTG N9831 (Alliance) Adjuvant Trastuzumab Trial Advani, Pooja P. , Ballman, Karla V. , Dockter, Travis J. ... - - J. Clin. Oncol - 2016 Manuscript - Primary - Long-Term-Followup - Breast - N9831
Clinical Utility of Metrics Based on Tumor Measurements in Phase II Trials to Predict Overall Survival Outcomes in Phase III Trials by Using Resampling Methods An, Ming-Wen , Han, Yu , Meyers, Jeffrey P. , Bogaerts, Jan ... - - J. Clin. Oncol - 2015 Manuscript - Secondary-not-in-original - Primary - GI - NCCTG-N9741
Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303 Bartlett, Nancy L. , Wilson, Wyndham H. , Jung, Sin-Ho , Hsi, Eric D. ... - - J. Clin. Oncol - 2019 Manuscript - Primary - Primary - Lymphoma - CALGB-50303
Feasibility of Implementing the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in a Multicenter Trial: NCCTG N1048 Basch, Ethan , Dueck, Amylou C. , Rogak, Lauren J. ... - - J. Clin. Oncol - 2018 Manuscript - Secondary-not-in-original - Primary - Health Outcome - N1048
Her2 gene expression and not Her2 amplification is predictive and prognostic in patients (pts) with metastatic colorectal cancer (mCRC) enrolled in CALGB/SWOG 80405 (Alliance) Battaglin, Francesca , Ou, Fang-Shu , Qu, Xueping ... - ASCO - J. Clin. Oncol - 2020 Abstract - Secondary-not-in-original - Primary - Correl Sci NOS - CALGB-80405
High-Dose Chemotherapy With Autologous Stem-Cell Support As Adjuvant Therapy in Breast Cancer: Overview of 15 Randomized Trials Berry, Donald A. , Ueno, Naoto T. , Johnson, Marcella M. ... - - J. Clin. Oncol - 2011 Manuscript - Secondary-not-in-original - Comprehensive - Breast - INT-0163
Impact of Young Age on Treatment Efficacy and Safety in Advanced Colorectal Cancer: A Pooled Analysis of Patients From Nine First-Line Phase III Chemotherapy Trials Blanke, Charles D. , Bot, Brian M. , Thomas, David M. ... - - J. Clin. Oncol - 2011 Manuscript - Secondary-not-in-original - Comprehensive - GI - N9741
Axillary Ultrasound After Neoadjuvant Chemotherapy and Its Impact on Sentinel Lymph Node Surgery: Results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance) Boughey, Judy C. , Ballman, Karla V. , Hunt, Kelly K. ... - - J. Clin. Oncol - 2015 Manuscript - Secondary - Primary - Breast - ACOSOG-Z1071
Prognostic Effect of Tumor Lymphocytic Infiltration in Resectable Non–Small-Cell Lung Cancer Brambilla, Elisabeth , Le Teuff, Gwénaël , Marguet, Sophie ... - - J. Clin. Oncol - 2016 Manuscript - Secondary - Primary - Respiratory - CALGB-9633
Endocrine Therapy With or Without Inhibition of Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor 2: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Fulvestrant With or Without Lapatinib for Postmenopausal Women With Hormone Receptor–Positive Advanced Breast Cancer—CALGB 40302 (Alliance) Burstein, Harold J. , Cirrincione, Constance T. , Barry, William T. ... - - J. Clin. Oncol - 2014 Manuscript - Primary - Primary - Breast - CALGB-40302
Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without Lapatinib Carey, Lisa A. , Berry, Donald A. , Cirrincione, Constance T. ... - - J. Clin. Oncol - 2016 Manuscript - Primary - Primary - Breast - CALGB-40601
Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN Trial Choueiri, Toni K. , Halabi, Susan , Sanford, Ben L. , Hahn, Olwen ... - - J. Clin. Oncol - 2017 Manuscript - Primary - Primary - GU - A031203
Incidence of Late Relapses in Patients With HER2-Positive Breast Cancer Receiving Adjuvant Trastuzumab: Combined Analysis of NCCTG N9831 (Alliance) and NRG Oncology/NSABP B-31 Chumsri, Saranya , Li, Zhuo , Serie, Daniel J. ... - - J. Clin. Oncol - 2019 Manuscript - Secondary-not-in-original - Primary - Breast - N9831 , NSABP B-31
Pathologic and Molecular Features Correlate With Long-Term Outcome After Adjuvant Therapy of Resected Primary GI Stromal Tumor: The ACOSOG Z9001 Trial Corless, Christopher L. , Ballman, Karla V. , Antonescu, Cristina R. ... - - J. Clin. Oncol - 2014 Manuscript - Secondary - Primary - GI - ACOSOG-Z9001
Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502 Devine, Steven M. , Owzar, Kouros , Blum, William , Mulkey, Flora ... - - J. Clin. Oncol - 2015 Manuscript - Primary - Primary - Transplant - CALGB-100103
Phase III Trial Evaluating Letrozole As First-Line Endocrine Therapy With or Without Bevacizumab for the Treatment of Postmenopausal Women With Hormone Receptor–Positive Advanced-Stage Breast Cancer: CALGB 40503 (Alliance) Dickler, Maura N. , Barry, William T. , Cirrincione, Constance T. ... - - J. Clin. Oncol - 2016 Manuscript - Primary - Primary - Breast - CALGB-40503
Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Celecoxib in Addition to Standard Chemotherapy for Advanced Non–Small-Cell Lung Cancer With Cyclooxygenase-2 Overexpression: CALGB 30801 (Alliance) Edelman, Martin J. , Wang, Xiaofei , Hodgson, Lydia ... - - J. Clin. Oncol - 2017 Manuscript - Primary - Primary - Respiratory - CALGB-30801
Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance) Ellis, Matthew J. , Suman, Vera J. , Hoog, Jeremy ... - - J. Clin. Oncol - 2017 Manuscript - Secondary - Primary - Breast - ACOSOG-Z1031B
CALGB 80403 (Alliance)/E1206: A Randomized Phase II Study of Three Chemotherapy Regimens Plus Cetuximab in Metastatic Esophageal and Gastroesophageal Junction Cancers Enzinger, Peter C. , Burtness, Barbara Ann , Niedzwiecki, Donna ... - - J. Clin. Oncol - 2016 Manuscript - Primary - Primary - GI - CALGB-80403 , ECOG-1206
Nut Consumption and Survival in Patients With Stage III Colon Cancer: Results From CALGB 89803 (Alliance) Fadelu, Temidayo , Zhang, Sui , Niedzwiecki, Donna , Ye, Xing ... - - J. Clin. Oncol - 2018 Manuscript - Secondary - Primary - GI - CALGB-89803
Impact of Brachytherapy on Local Recurrence Rates After Sublobar Resection: Results From ACOSOG Z4032 (Alliance), a Phase III Randomized Trial for High-Risk Operable Non–Small-Cell Lung Cancer Fernando, Hiran C. , Landreneau, Rodney J. , Mandrekar, Sumithra J. ... - - J. Clin. Oncol - 2014 Manuscript - Primary - Primary - Respiratory - ACOSOG-Z4032
Accrual of Older Patients With Breast Cancer to Alliance Systemic Therapy Trials Over Time: Protocol A151527 Freedman, Rachel A. , Foster, Jared C. , Seisler, Drew K. ... - - J. Clin. Oncol - 2017 Manuscript - Primary - Primary - Older Adult - A151527 , ACOSOG-Z1031 , ACOSOG-Z1041 , C8541 , C9344 , C9741 , CALGB-40101 , CALGB-40302 , CALGB-40502 , CALGB-40503 , CALGB-40601 , CALGB-40603 , CALGB-49907 , CALGB-9342 , CALGB-9840 , N89-30-52 , N9831
Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance) Fuchs, Charles S. , Niedzwiecki, Donna , Mamon, Harvey J. ... - - J. Clin. Oncol - 2017 Manuscript - Primary - Primary - GI - CALGB-80101
Coffee Intake, Recurrence, and Mortality in Stage III Colon Cancer: Results From CALGB 89803 (Alliance) Guercio, Brendan J. , Sato, Kaori , Niedzwiecki, Donna , Ye, Xing ... - - J. Clin. Oncol - 2015 Manuscript - Secondary - Primary - Prevention - C89803
Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men With Castration-Resistant Prostate Cancer Halabi, Susan , Kelly, William Kevin , Ma, Hua , Zhou, Haojin ... - - J. Clin. Oncol - 2016 Manuscript - Secondary-not-in-original - Comprehensive - GU - CALGB-90601
Updated Prognostic Model for Predicting Overall Survival in First-Line Chemotherapy for Patients With Metastatic Castration-Resistant Prostate Cancer Halabi, Susan , Lin, Chen-Yen , Kelly, W. Kevin , Fizazi, Karim S. ... - - J. Clin. Oncol - 2014 Manuscript - Secondary-not-in-original - Primary - GU - CALGB-90401
Topoisomerase IIα Amplification Does Not Predict Benefit From Dose-Intense Cyclophosphamide, Doxorubicin, and Fluorouracil Therapy in HER2-Amplified Early Breast Cancer: Results of CALGB 8541/150013 Harris, Lyndsay N. , Broadwater, Gloria , Abu-Khalaf, Maysa ... - - J. Clin. Oncol - 2009 Manuscript - Secondary - Primary - Correl Sci NOS - CALGB-150013 , C8541
On-treatment changes of plasma protein biomarkers in CALGB/SWOG 80405 (Alliance) Hatch, Ace J. , Ou, Fang-Shu , Zemla, Tyler , Liu , Star, Mark D. ... - ASCO GI - J. Clin. Oncol - 2019 Abstract - Secondary-not-in-original - Primary - GI - CALGB-80405
Benefits and Adverse Events in Younger Versus Older Patients Receiving Adjuvant Chemotherapy for Colon Cancer: Findings From the Adjuvant Colon Cancer Endpoints Data Set Hubbard, Joleen , Thomas, David M. , Yothers, Greg , Green, Erin ... - - J. Clin. Oncol - 2012 Manuscript - Secondary - Comprehensive - GI - ACCENT , CALGB-89803
Phase II Single-Arm Study of Preoperative Letrozole for Estrogen Receptor–Positive Postmenopausal Ductal Carcinoma In Situ: CALGB 40903 (Alliance) Hwang, E. Shelley , Hyslop, Terry , Hendrix, Laura H. ... - - J. Clin. Oncol - 2020 Manuscript - Primary - Primary - Breast - CALGB-40903
Mutational Analysis of Patients With Colorectal Cancer in CALGB/SWOG 80405 Identifies New Roles of Microsatellite Instability and Tumor Mutational Burden for Patient Outcome Innocenti, Federico , Ou, Fang-Shu , Qu, Xueping , Zemla, Tyler J. ... - - J. Clin. Oncol - 2019 Manuscript - Secondary-not-in-original - Primary - Correl Sci NOS - CALGB-80405
Radiation Field Design in the ACOSOG Z0011 (Alliance) Trial Jagsi, Reshma , Chadha, Manjeet , Moni, Janaki , Ballman, Karla ... - - J. Clin. Oncol - 2014 Manuscript - Secondary - Primary - Breast - ACOSOG-Z0011
Randomized, Double-Blind, Placebo-Controlled Phase III Trial Comparing Docetaxel and Prednisone With or Without Bevacizumab in Men With Metastatic Castration-Resistant Prostate Cancer: CALGB 90401 Kelly, William Kevin , Halabi, Susan , Carducci, Michael ... - - J. Clin. Oncol - 2012 Manuscript - Primary - Primary - GU - CALGB-90401
Doxepin Rinse Versus Placebo in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Head and Neck Radiotherapy With or Without Chemotherapy: A Phase III, Randomized, Double-Blind Trial (NCCTG-N09C6 [Alliance]) Leenstra, James L. , Miller, Robert C. , Qin, Rui ... - - J. Clin. Oncol - 2014 Manuscript - Primary - Primary - Symptom Inter - N09C6
Randomized Trial of Lenalidomide Alone Versus Lenalidomide Plus Rituximab in Patients With Recurrent Follicular Lymphoma: CALGB 50401 (Alliance) Leonard, John P. , Jung, Sin-Ho , Johnson, Jeffrey ... - - J. Clin. Oncol - 2015 Manuscript - Primary - Primary - Lymphoma - CALGB-50401
Identification of a 24-Gene Prognostic Signature That Improves the European LeukemiaNet Risk Classification of Acute Myeloid Leukemia: An International Collaborative Study Li, Zejuan , Herold, Tobias , He, Chunjiang , Valk, Peter J.M. ... - - J. Clin. Oncol - 2013 Manuscript - Secondary-not-in-original - Meta-Analysis - Leukemia - CALGB-19808 , CALGB-9222 , CALGB-9621 , CALGB-9710 , CALGB-9720
Effect of Pretreatment Renal Function on Treatment and Clinical Outcomes in the Adjuvant Treatment of Older Women With Breast Cancer: Alliance A171201, an Ancillary Study of CALGB/CTSU 49907 Lichtman, Stuart M. , Cirrincione, Constance T. , Hurria, Arti ... - - J. Clin. Oncol - 2016 Manuscript - Secondary - Primary - Older Adult - A171201 , CALGB-49907
Phase III Randomized, Placebo-Controlled, Double-Blind Study of Intravenous Calcium and Magnesium to Prevent Oxaliplatin-Induced Sensory Neurotoxicity (N08CB/Alliance) Loprinzi, Charles L. , Qin, Rui , Dakhil, Shaker R. ... - - J. Clin. Oncol - 2014 Manuscript - Primary - Primary - Symptom Inter - N08CB
Epigenetics Meets Genetics in Acute Myeloid Leukemia: Clinical Impact of a Novel Seven-Gene Score Marcucci, Guido , Yan, Pearlly , Maharry, Kati , Frankhouser, David ... - - J. Clin. Oncol - 2014 Manuscript - Secondary - Primary - Leuk Corr Sci - CALGB-10201 , CALGB-9420 , CALGB-9720 , CALGB-9621 , CALGB-19808
Detection of Occult Micrometastases in Patients With Clinical Stage I Non–Small-Cell Lung Cancer: A Prospective Analysis of Mature Results of CALGB 9761 (Alliance) Martin, Linda W. , D’Cunha, Jonathan , Wang, Xiaofei , Herzan, Debra ... - - J. Clin. Oncol - 2016 Manuscript - Primary - Long-Term-Followup - Respiratory - C9761
Event-Free Survival at 24 Months Is a Robust End Point for Disease-Related Outcome in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy Maurer, Matthew J. , Ghesquières, Hervé , Jais, Jean-Philippe ... - - J. Clin. Oncol - 2014 Manuscript - Secondary - Primary - Lymphoma - N0489
Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis McCarthy, Philip L. , Holstein, Sarah A. , Petrucci, Maria Teresa ... - - J. Clin. Oncol - 2017 Manuscript - Secondary-not-in-original - Primary - Myeloma - CALGB-100104
Impact of Age on the Efficacy of Newer Adjuvant Therapies in Patients With Stage II/III Colon Cancer: Findings From the ACCENT Database McCleary, Nadine J. , Meyerhardt, Jeffrey A. , Green, Erin ... - - J. Clin. Oncol - 2013 Manuscript - Secondary - Primary - GI - NCCTG-N0441
Phase I and Pharmacokinetic Study of Sorafenib in Patients With Hepatic or Renal Dysfunction: CALGB 60301 Miller, Antonius A. , Murry, Daryl J. , Owzar, Kouros ... - - J. Clin. Oncol - 2009 Manuscript - Primary - Primary - Experimental - CALGB-60301
Evaluation of the Stage IB Designation of the American Joint Committee on Cancer Staging System in Breast Cancer Mittendorf, Elizabeth A. , Ballman, Karla V. , McCall, Linda M. ... - - J. Clin. Oncol - 2015 Manuscript - Secondary - Primary - Breast - ACOSOG-Z0010
Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial Muss, Hyman B. , Polley, Mei-Yin C. , Berry, Donald A. , Liu, Heshan ... - - J. Clin. Oncol - 2019 Manuscript - Primary - Long-Term-Followup - Breast - CALGB-49907
Association Between Results of a Gene Expression Signature Assay and Recurrence-Free Interval in Patients With Stage II Colon Cancer in Cancer and Leukemia Group B 9581 (Alliance) Niedzwiecki, Donna , Frankel, Wendy L. , Venook, Alan P. , Ye, Xing ... - - J. Clin. Oncol - 2016 Manuscript - Secondary - Primary - Correl Sci NOS - CALGB-150705 , C9581
Clinical Course of Oxaliplatin-Induced Neuropathy: Results From the Randomized Phase III Trial N08CB (Alliance) Pachman, Deirdre R. , Qin, Rui , Seisler, Drew K. , Smith, Ellen M.L. ... - - J. Clin. Oncol - 2015 Manuscript - Secondary - Primary - Symptom Inter - N08CB
Ethics of Mandatory Research Biopsy for Correlative End Points Within Clinical Trials in Oncology Peppercorn, Jeffrey , Shapira, Iuliana , Collyar, Deborah ... - - J. Clin. Oncol - 2010 Manuscript - No-Endpoint - Comprehensive - Ethics - No Study Assigned
Trastuzumab Plus Adjuvant Chemotherapy for Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Planned Joint Analysis of Overall Survival From NSABP B-31 and NCCTG N9831 Perez, Edith A. , Romond, Edward H. , Suman, Vera J. ... - - J. Clin. Oncol - 2014 Manuscript - Primary - Comprehensive - Breast - N9831
Genomic Analysis Reveals That Immune Function Genes Are Strongly Linked to Clinical Outcome in the North Central Cancer Treatment Group N9831 Adjuvant Trastuzumab Trial Perez, Edith A. , Thompson, E. Aubrey , Ballman, Karla V. ... - - J. Clin. Oncol - 2015 Manuscript - Secondary - Primary - Breast - N9831
Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial Piccart-Gebhart, Martine , Holmes, Eileen , Baselga, José ... - - J. Clin. Oncol - 2016 Manuscript - Primary - Primary - Breast - N063D
Chemotherapy With or Without Maintenance Sunitinib for Untreated Extensive-Stage Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase II Study—CALGB 30504 (Alliance) Ready, Neal E. , Pang, Herbert H. , Gu, Lin , Otterson, Gregory A. ... - - J. Clin. Oncol - 2015 Manuscript - Primary - Primary - Respiratory - CALGB-30504
Absolute Benefit of Adjuvant Endocrine Therapies for Premenopausal Women With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Early Breast Cancer: TEXT and SOFT Trials Regan, Meredith M. , Francis, Prudence A. , Pagani, Olivia ... - - J. Clin. Oncol - 2016 Manuscript - Secondary - Primary - Breast - IBCSG-24-02 (SOFT-TEXT)
Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian Function Trial Ribi, Karin , Luo, Weixiu , Bernhard, Jürg , Francis, Prudence A. ... - - J. Clin. Oncol - 2016 Manuscript - Primary - Primary - Breast - IBCSG-24-02 (SOFT-TEXT)
Randomized Phase III Trial of Paclitaxel Once Per Week Compared With Nanoparticle Albumin-Bound Nab-Paclitaxel Once Per Week or Ixabepilone With Bevacizumab As First-Line Chemotherapy for Locally Recurrent or Metastatic Breast Cancer: CALGB 40502/NCCTG N063H (Alliance) Rugo, Hope S. , Barry, William T. , Moreno-Aspitia, Alvaro ... - - J. Clin. Oncol - 2015 Manuscript - Primary - Primary - Breast - CALGB-40502
Treatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Therapy Trials Saha, Poornima , Regan, Meredith M. , Pagani, Olivia ... - - J. Clin. Oncol - 2017 Manuscript - Secondary - Primary - Breast - IBCSG-24-02 (SOFT-TEXT)
Cost-Effectiveness Analysis of Monthly Zoledronic Acid, Zoledronic Acid Every 3 Months, and Monthly Denosumab in Women With Breast Cancer and Skeletal Metastases: CALGB 70604 (Alliance) Shapiro, Charles L. , Moriarty, James P. , Dusetzina, Stacie ... - - J. Clin. Oncol - 2017 Manuscript - Secondary - Primary - Symptom Inter - CALGB-70604
Resampling the N9741 Trial to Compare Tumor Dynamic Versus Conventional End Points in Randomized Phase II Trials Sharma, Manish R. , Gray, Elizabeth , Goldberg, Richard M. ... - - J. Clin. Oncol - 2015 Manuscript - Secondary-not-in-original - Primary - GI - N9741
Pooled Analysis of the Prognostic and Predictive Effects of KRAS Mutation Status and KRAS Mutation Subtype in Early-Stage Resected Non–Small-Cell Lung Cancer in Four Trials of Adjuvant Chemotherapy Shepherd, Frances A. , Domerg, Caroline , Hainaut, Pierre ... - - J. Clin. Oncol - 2013 Manuscript - Secondary-not-in-original - Comprehensive - Respiratory - CALGB-9633
Frailty and Adherence to Adjuvant Hormonal Therapy in Older Women With Breast Cancer: CALGB Protocol 369901 Sheppard, Vanessa B. , Faul, Leigh Anne , Luta, George ... - - J. Clin. Oncol - 2014 Manuscript - Secondary - Primary - Older Adult - CALGB-369901
Comparison of Doxorubicin and Cyclophosphamide Versus Single-Agent Paclitaxel As Adjuvant Therapy for Breast Cancer in Women With 0 to 3 Positive Axillary Nodes: CALGB 40101 (Alliance) Shulman, Lawrence N. , Berry, Donald A. , Cirrincione, Constance T. ... - - J. Clin. Oncol - 2014 Manuscript - Secondary - Primary - Breast - CALGB-40101
Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance) Sikov, William M. , Berry, Donald A. , Perou, Charles M. ... - - J. Clin. Oncol - 2015 Manuscript - Primary - Primary - Breast - CALGB-40603
Prognostic Impact of Deficient DNA Mismatch Repair in Patients With Stage III Colon Cancer From a Randomized Trial of FOLFOX-Based Adjuvant Chemotherapy Sinicrope, Frank A. , Mahoney, Michelle R. , Smyrk, Thomas C. ... - - J. Clin. Oncol - 2013 Manuscript - Secondary-not-in-original - Primary - Correl Sci NOS - CALGB-89803 , N0147
Randomized Controlled Trial of Early Zoledronic Acid in Men With Castration-Sensitive Prostate Cancer and Bone Metastases: Results of CALGB 90202 (Alliance) Smith, Matthew R. , Halabi, Susan , Ryan, Charles J. , Hussain, Arif ... - - J. Clin. Oncol - 2014 Manuscript - Primary - Primary - GU - CALGB-90202
Assessing the Impact of a Cooperative Group Trial on Breast Cancer Care in the Medicare Population Soulos, Pamela R. , Yu, James B. , Roberts, Kenneth B. ... - - J. Clin. Oncol - 2012 Manuscript - Secondary-not-in-original - Primary - Older Adult - CALGB-9343
Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection Tsao, Ming-Sound , Marguet, Sophie , Le Teuff, Gwénaël ... - - J. Clin. Oncol - 2015 Manuscript - Secondary-not-in-original - Primary - Respiratory - CALGB-9633
A phase II study of pre- and post-operative gemcitabine and erlotinib plus pancreaticoduodenectomy (PD) for patients with resectable pancreatic ductal adenocarcinoma (PDAC): ACOSOG/ Alliance Z5041 Trial Wei, Alice Chia-chi , Ou, Fang-Shu , Shi, Qian ... - ASCO - J. Clin. Oncol - 2018 Abstract - Primary - Primary - GI - ACOSOG-Z5041
